PineBridge Investments’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-31,298
| Closed | -$743K | – | 997 |
|
|
2019
Q4 | $743K | Sell |
31,298
-15,969
| -34% | -$379K | 0.01% | 716 |
|
|
2019
Q3 | $1.3M | Buy |
47,267
+4,087
| +9% | +$112K | 0.02% | 620 |
|
|
2019
Q2 | $1.43M | Buy |
43,180
+29,795
| +223% | +$986K | 0.02% | 496 |
|
|
2019
Q1 | $469K | Buy |
13,385
+303
| +2% | +$10.6K | 0.01% | 715 |
|
|
2018
Q4 | $434K | Buy |
13,082
+2,113
| +19% | +$70.1K | 0.01% | 720 |
|
|
2018
Q3 | $552K | Buy |
10,969
+2,473
| +29% | +$124K | 0.01% | 726 |
|
|
2018
Q2 | $509K | Sell |
8,496
-446
| -5% | -$26.7K | 0.01% | 695 |
|
|
2018
Q1 | $410K | Sell |
8,942
-10,251
| -53% | -$470K | 0.01% | 725 |
|
|
2017
Q4 | $765K | Buy |
19,193
+12,901
| +205% | +$514K | 0.02% | 662 |
|
|
2017
Q3 | $252K | Sell |
6,292
-332
| -5% | -$13.3K | 0.01% | 795 |
|
|
2017
Q2 | $285K | Buy |
6,624
+86
| +1% | +$3.7K | 0.01% | 735 |
|
|
2017
Q1 | $205K | Buy |
6,538
+243
| +4% | +$7.62K | 0.01% | 794 |
|
|
2016
Q4 | $159K | Hold |
6,295
| – | – | ﹤0.01% | 884 |
|
|
2016
Q3 | $155K | Buy |
6,295
+1,907
| +43% | +$47K | 0.01% | 609 |
|
|
2016
Q2 | $89K | Buy |
4,388
+364
| +9% | +$7.38K | ﹤0.01% | 812 |
|
|
2016
Q1 | $61K | Sell |
4,024
-572
| -12% | -$8.67K | ﹤0.01% | 875 |
|
|
2015
Q4 | $62K | Buy |
4,596
+1,005
| +28% | +$13.6K | ﹤0.01% | 898 |
|
|
2015
Q3 | $51K | Buy |
3,591
+332
| +10% | +$4.72K | ﹤0.01% | 929 |
|
|
2015
Q2 | $56K | Buy |
+3,259
| New | +$56K | ﹤0.01% | 924 |
|